The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Life Science Market Reports

SynopsisVCF is characterized by the collapse of one or more vertebral bodies, resulting in persistent and unbearable pain in patients. Osteoporosis, a degenerative bone disease, is a leading cause of VCF among elderly women. Metastatic bone disease, multiple myeloma, .....

No Of Pages : 62
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisMainly used to treat congenital and acquired coagulation factor II, VII, IX, and X deficiencies (alone or in combination) including: coagulation factor IX deficiency (hemophilia B), and coagulation factor II, VII, X deficiency overdose of anticoagulants, vitam.....

No Of Pages : 92
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisThe stem cells, which are stimulated by the drug, replenish or restore cells associated with the induction of hair growth. The global Stem Cell Alopecia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, w.....

No Of Pages : 73
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisThe global Portable Lung Monitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Portable Lung Monitors is estimated to incr.....

No Of Pages : 100
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisThe global Medical Vision Screeners market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devices is.....

No Of Pages : 179
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisPonatinib HCl, also known by its brand name Iclusig, is a medication used in the treatment of certain types of cancer. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs). Ponatinib specifically targets and inhibits abnormal tyrosine kinase.....

No Of Pages : 90
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisLinezolid is a synthetic antibiotic, the first of the oxazolidinone class, used for the treatment of infections caused by multi-resistant bacteria including streptococcus and methicillin-resistant Staphylococcus aureus (MRSA). The drug works by inhibiting the .....

No Of Pages : 79
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00

SynopsisHuman Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. .....

No Of Pages : 95
Publication Date: Mar, 2025
Single User Price : US$ 2,900.00